Robotic-Assisted Versus Manual Electrode Array Insertion
Iowa Cochlear Implant Clinical Research Center Study on Robotic-Assisted Versus Manual Electrode Array Insertion
1 other identifier
interventional
100
1 country
1
Brief Summary
Robotics-assisted electrode insertion overcomes many surgeon-related kinetic limitations such as insertion speed, tremor, drift, and lack of accurate force control. In human cadaveric cochleae, robotics-assisted electrode insertion causes less intracochlear trauma compared to manual insertion. Whether this technical advance results in functional benefits in CI patients remains unknown. To address this critical knowledge gap, the investigators will compare cochlear trauma assessed using CT scans, cochlear and AN function assessed using ECochG and/or the eCAP, and clinical outcomes quantified by postoperative residual acoustic hearing and speech perception scores between participants randomized to either manual or robotics-assisted electrode array insertion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2025
CompletedFirst Posted
Study publicly available on registry
April 30, 2025
CompletedStudy Start
First participant enrolled
June 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
July 17, 2025
June 1, 2025
2.8 years
April 15, 2025
July 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
scalar translocation
Postoperative CT scan will be used to assess scalar translocation
Postoperative standard of care CT (approximately at activation or 2 weeks)
Angular Insertion depth
Angle of the electrode array inside the cochlea, measured relative to the round window membrane.
Postoperative standard of care CT (approximately at activation or 2 weeks)
Secondary Outcomes (1)
Impedance
initial activation and at 3 and 6 months post CI
Study Arms (2)
Robot
EXPERIMENTALThe iotaSOFT™ Insertion System is an FDA approved cochlear implant (CI) electrode array insertion tool. It will be used to assist the surgeon with the cochlear implant insertion.
Manual
NO INTERVENTIONManual cochlear implant surgical procedure without robotic assistance.
Interventions
The iotaSOFT™ Insertion System is an FDA approved cochlear implant (CI) electrode array insertion tool. It provides surgeons with consistent insertion speed and force. The system consists of a drive unit connected to a touch screen control console and foot pedal interface. The surgeon secures the base to the skull with two pre-loaded self-drilling bone screws. The drive unit is placed into the base and the adjustable drive head is coupled to a CI electrode. Before insertion begins, the surgeon selects the desired speed of insertion. the surgeon controls the electrode insertion forward and reverse motion via foot pedal while guiding the electrode array into the cochlea with standard CI instrumentation. Upon the completion of electrode array insertion, the drive head and unit are uncoupled from the electrode lead and removed from the patient for disposal.
Eligibility Criteria
You may qualify if:
- Candidate for a cochlear implant according to CMS guidelines
- Willingness to comply with all study requirements
- Patent cochlea and normal cochlear anatomy, as confirmed by preoperative imaging
- English speaking
You may not qualify if:
- Medical or psychological conditions that contraindicate undergoing surgery
- Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array.
- Unrealistic expectations on the part of the candidate and/or candidate's family, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa Healthcare
Iowa City, Iowa, 52242, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Bruce Gantz, MD
University of Iowa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair Emeritus, Department of Otolaryngology--Head and Neck Surgery
Study Record Dates
First Submitted
April 15, 2025
First Posted
April 30, 2025
Study Start
June 30, 2025
Primary Completion (Estimated)
March 31, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
July 17, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
Aggregated data will be shared. Individual primary and secondary outcomes are too complex for IPD